Source BioScience Expands Genomic Footprint

The opening of the Cambridge Genomics facility.
L – R: Klaudyna Johnstone (Marketing Director), Dave Negus (Group Sequencing Manager), Richard Stevens (Director of Genomics), Jay LeCoque ( Chairman and CEO) and Tony Ratcliffe (Chief Financial Officer)

Source BioScience Signals Growth with the Opening of New Cambridge Genomics and Precision Medicine Unit

This month – February 2023 โ€“ we welcomed the launch of our new facility in Cambridge, showcasing the expansion of our state-of-the-art laboratories for genomics and precision medicine.

With genomic medicine and precision therapeutics being at the heart of bioscience developments, we are thrilled to level-up our contributions to the field and strengthen our ability to partner with life science academia, pharmaceutical and biotechnology organisations in reaching their research goals.

The expansion of this laboratory space mirrors our commitment to providing market-leading genomic and precision medicine services; fuelling the growth of genomic advancements as they evolve.

After the successful launch of our new genomics and precision medicine facility in Cambridge, read the media coverage here:

Contact us today and one of our skilled account managers will be in touch with a free consultation including further information and pricing details.

Share this article